AECOM (ACM) Stock News
NYSE:ACM - New York Stock Exchange, Inc. - US00766T1007 - Common Stock - Currency: USD
ACM Latest News, Press Relases and Analysis
Do Options Traders Know Something About AECOM Stock We Don't?
Investors need to pay close attention to ACM stock based on the movements in the options market lately.
3 Inflated Stocks in the Doghouse
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
AECOM to Support King Fahd Stadium Transformation for Vision 2030
ACM to supervise King Fahd Stadium improvements, aligning with Saudi Arabia's Vision 2030 and preparing for major international events.
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
3 Reasons Growth Investors Will Love Aecom (ACM)
Aecom (ACM) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's Why Aecom Technology (ACM) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
MasTec Gains 18% in 3 Months: Should Investors Buy the Stock Now?
MTZ's strong backlog and strong non-pipeline segments highlight its resilience amid market shifts.
ACM Q1 Earnings Call: Margins Improve Despite Revenue Decline; Guidance Edges Up
Infrastructure consulting service company AECOM (NYSE:ACM) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 4.4% year on year to $3.77 billion. Its non-GAAP profit of $1.25 per share was 4.8% above analysts’ consensus estimates.
Why Biohaven Stock Dove by Nearly 20% on Thursday
Volatile biotech stock Biohaven (NYSE: BHVN) is prone to sharp movements both up and down. After market close on Wednesday, Biohaven divulged that the U.S. Food and Drug Administration's (FDA) Division of Neurology 1 is extending the due date for its decision on a very promising pipeline drug developed by the company. Specifically, the FDA unit is extending the Prescription Drug User Fee Act (PDUFA) date for Biohaven's troriluzole, a treatment that targets brain disorder spinocerebellar ataxia (SCA), by three months.
Is AECOM (ACM) Stock Outpacing Its Construction Peers This Year?
Here is how Aecom Technology (ACM) and Primoris Services (PRIM) have performed compared to their sector so far this year.
Mentions: PRIM
Aecom Technology (ACM) Crossed Above the 200-Day Moving Average: What That Means for Investors
Is it a good or bad thing when a stock surpasses resistance at the 200-day simple moving average?
Kilroy reports lackluster earnings as West Coast tenants downsize
Kilroy Realty’s Angela Aman with 384 Oyster Point Boulevard (Edward Carreon, Google Maps, Getty)Kilroy Realty’s earnings last quarter were fair to middling as office and life sciences occupancy slackened further across its 17.1-million-square-foot portfolio in San Francisco, Los Angeles, Seattle and San Diego, the company reported Tuesday. Kilroy’s funds from operations were $122.3 million, or $1.02 per diluted share in […]This article originally appeared on The Real Deal. Click here to read the
LPX Stock Gains on Q1 Earnings & Sales Beat, '25 Siding View Up
Louisiana-Pacific's first-quarter 2025 earnings reflect strong Siding business performance, partially offset by a decline in OSB prices and volumes. Know more here.
AECOM Tops Q2 Earnings, Misses on Revenue, Boosts 2025 View
ACM's fiscal second-quarter results benefit from high-returning organic growth initiatives.
Aecom Technology (ACM) Beats Q2 Earnings Estimates
Aecom (ACM) delivered earnings and revenue surprises of 8.70% and 1.68%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: VSEC
AECOM reports second quarter fiscal 2025 results
Sempra (SRE): Among Large-Cap Stocks Insiders Were Buying in Q1 2025 Before Trump’s Tariff Shockwave
We recently published a list of 12 Large-Cap Stocks Insiders Were Buying in Q1 2025 Before Trump’s Tariff Shockwave. In this article, we are going to take a look at where Sempra (NYSE:SRE) stands against other large-cap stocks insiders were buying in Q1 2025 before Trump’s tariff shockwave. US stocks surged last week following President […]
American Express Company (AXP): Among the Best Fintech Stocks to Buy in 2025
We recently compiled a list of the 12 Best Fintech Stocks to Buy in 2025. In this article, we are going to take a look at where American Express Company (NYSE:AXP) stands against the other fintech stocks. The terms finance and technology are combined to form the term fintech. This wide category includes companies that integrate […]
Why Transocean Stock Lost Over 3% of its Value Today
The specialty oil and gas company released its first-quarter results. Its revenue fell on a year-over-year basis, and it flipped into the red on the bottom line. Transocean's first-quarter figures were topped by a revenue line of $906 million, representing a nearly 5% year-over-year decline.
EMCOR Gears Up to Post Q1 Earnings: Buy, Sell or Hold the Stock?
Robust backlog, earnings growth, and a discount valuation - EME stock is a buy before Q1 earnings?
EMCOR vs. MasTec: Which Infrastructure Stock Is the Better Buy Now?
With strong Infrastructure momentum, which stock looks more promising, EME or MTZ?